Back to Search Start Over

Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort.

Authors :
Bermejo-Pareja, Félix
Contador, Israel
Trincado, Rocío
Lora, David
Sánchez-Ferro, Álvaro
Mitchell, Alex J.
Boycheva, Elina
Herrero, Alejandro
Hernández-Gallego, Jesús
Llamas, Sara
Galende, Alberto Villarejo
Benito-León, Julián
Villarejo Galende, Alberto
Source :
Journal of Alzheimer's Disease. 2016, Vol. 50 Issue 3, p719-731. 13p.
Publication Year :
2016

Abstract

<bold>Background: </bold>The predictive value of diverse subtypes of mild cognitive impairment (MCI) for dementia and death is highly variable.<bold>Objective: </bold>To compare the predictive value of several MCI subtypes in progression to dementia and/or mortality in the NEDICES (Neurological Disorders in Central Spain) elderly cohort.<bold>Methods: </bold>Retrospect algorithmic MCI subgroups were established in a non-dementia baseline NEDICES cohort using Spanish adaptations of the original Mini-Mental State Examination (MMSE-37) and Pfeffer's Functional Activities Questionnaire (Pfeffer-11). The presence of MCI was defined according two cognitive criteria: using two cut-offs points on the total MMSE-37 score. Five cognitive domains were used to establish the MCI subtypes. Functional capacity (Pfeffer-11) was preserved or minimally impaired in all MCI participants. The incident dementia diagnoses were established by specialists and the mortality data obtained from Spanish official registries.<bold>Results: </bold>3,411 participants without dementia were assessed in 1994-5. The baseline prevalence of MCI varied according to the MCI definition (4.3%-31.8%). The follow-up was a mean of 3.2 years (1997-8). The dementia incidence varied between 14.9 and 71.8 per 1,000/person-years. The dementia conversion rate was increased in almost all MCI subgroups (p >  0.01), and mortality rate was raised only in four MCI subtypes. The amnestic-multi-domain MCI (aMd-MCI) had the best dementia predictive accuracy (highest positive likelihood ratio and highest clinical utility when negative).<bold>Conclusions: </bold>Those with aMd-MCI were at greatest risk of progression to dementia, as in other surveys and might be explored with increased attention in MCI research and in dementia preventive trials. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13872877
Volume :
50
Issue :
3
Database :
Academic Search Index
Journal :
Journal of Alzheimer's Disease
Publication Type :
Academic Journal
Accession number :
112844707
Full Text :
https://doi.org/10.3233/JAD-150625